Histone lysine demethylase (kdm) subfamily 4: Structures, functions and therapeutic potential

American Journal of Translational Research

Volumn 6, Issue 1, 2014, Pages 1-15

  Labbé, Roselyne M ^a   Holowatyj, Andreana ^a   Yang, Zeng Quan ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Histone lysine demethylase; JmjC domain; KDM4

Indexed keywords

HISTONE DEMETHYLASE; HISTONE LYSINE DEMETHYLASE SUBFAMILY 4; IRON; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN C; UNCLASSIFIED DRUG; ZINC;

BREAST CANCER; CAENORHABDITIS ELEGANS; CANCER RECURRENCE; CARCINOGENESIS; CHROMOSOME 9; DNA REPLICATION; DROSOPHILA MELANOGASTER; EMBRYO DEVELOPMENT; EPIGENETICS; GENE ACTIVATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CHROMOSOME; HYPOXIA; META ANALYSIS; METASTASIS; MISMATCH REPAIR; NONHUMAN; PLACENTAL MAMMALS; PROTEIN STRUCTURE; PSEUDOGENE; REGULATORY MECHANISM; REVIEW; SQUAMOUS CELL CARCINOMA;

EID: 84903155987     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Review

References (101)

1. [1] Jack AP, Bussemer S, Hahn M, Pünzeler S, Sny-der M, Wells M, Csankovszki G, Solovei I, Schotta G and Hake SB. H3K56me3 is a novel, conserved heterochromatic mark that largely but not completely overlaps with H3K9me3 in both regulation and localization. PLoS One 2013; 8: e51765.
2. [2] Lachner M, O’Sullivan RJ and Jenuwein T. An epigenetic road map for histone lysine methyl-ation. J Cell Sci 2003; 116: 2117-2124.
3. [3] Margueron R, Trojer P and Reinberg D. The key to development: interpreting the histone code? Curr Opin Genet Dev 2005; 15: 163-176.
4. [4] Martin C and Zhang Y. The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol 2005; 6: 838-849.
5. [5] Berry WL and Janknecht R. KDM4/JMJD2 his-tone demethylases: epigenetic regulators in cancer cells. Cancer Res 2013; 73: 2936-2942.
6. [6] Ding X, Pan H, Li J, Zhong Q, Chen X, Dry SM and Wang CY. Epigenetic activation of AP1 promotes squamous cell carcinoma metastasis. Sci Signal 2013; 6: ra28, 1-13, S0-15.
7. [7] Feng Q, Wang H, Ng HH, Erdjument-Bromage H, Tempst P, Struhl K and Zhang Y. Methylation of H3-Lysine 79 Is Mediated by a New Family of HMTases without a SET Domain. Current Biology 2002; 12: 1052-1058.
8. [8] Lacoste N, Utley RT, Hunter JM, Poirier GG and Côté J. Disruptor of Telomeric Silencing-1 Is a Chromatin-specifc Histone H3 Methyltransfer-ase. J Biol Chem 2002; 277: 30421-30424.
9. [9] Ng HH, Feng Q, Wang H, Erdjument-Bromage H, Tempst P, Zhang Y and Struhl K. Lysine methylation within the globular domain of his-tone H3 by Dot1 is important for telomeric silencing and Sir protein association. Genes Dev 2002; 16: 1518-1527.
10. [10] van Leeuwen F. Dot1p modulates silencing in yeast by methylation of the nucleosome core. Cell 2002; 109: 745-756.
11. [11] Krishnakumar R, Gamble MJ, Frizzell KM, Ber-rocal JG, Kininis M and Kraus WL. Reciprocal binding of PARP-1 and histone H1 at promoters specifes transcriptional outcomes. Science 2008; 319: 819-821.
12. [12] Trojer P, Zhang J, Yonezawa M, Schmidt A, Zheng H, Jenuwein T and Reinberg D. Dynamic Histone H1 Isotype 4 Methylation and Demeth-ylation by Histone Lysine Methyltransferase G9a/KMT1C and the Jumonji Domain-containing JMJD2/KDM4 Proteins. J Biol Chem 2009; 284: 8395-8405.
13. [13] Tu S, Bulloch EM, Yang L, Ren C, Huang WC, Hsu PH, Chen CH, Liao CL, Yu HM, Lo WS, Frei-tas MA and Tsai MD. Identification of histone demethylases in Saccharomyces cerevisiae. J Biol Chem 2007; 282: 14262-14271.
14. [14] Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA and Casero RA. Histone demethyl-ation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004; 119: 941-953.
15. [15] Lee MG, Wynder C, Cooch N and Shiekhattar R. An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation. Nature 2005; 437: 432-435.
16. [16] Metzger E, Wissmann M, Yin N, Muller JM, Schneider R, Peters AH, Gunther T, Buettner R and Schule R. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 2005; 437: 436-439.
17. [17] Klose RJ, Kallin EM and Zhang Y. JmjC-domain-containing proteins and histone demethyl-ation. Nat Rev Genet 2006; 7: 715-727.
18. [18] Klose RJ and Zhang Y. Regulation of histone methylation by demethylimination and de-methylation. Nat Rev Mol Cell Biol 2007; 8: 307-318.
19. [19] Katoh Y and Katoh M. Comparative integromics on JMJD2A, JMJD2B and JMJD2C: preferential expression of JMJD2C in undifferentiated ES cells. Int J Mol Med 2007; 20: 269-273.
20. [20] Whetstine JR, Nottke A, Lan F, Huarte M, Smo-likov S, Chen Z, Spooner E, Li E, Zhang G, Co-laiacovo M and Shi Y. Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell 2006; 125: 467-481.
21. [21] Hillringhaus L, Yue WW, Rose NR, Ng SS, Gile-adi C, Loenarz C, Bello SH, Bray JE, Schofeld CJ and Oppermann U. Structural and evolutionary basis for the dual substrate selectivity of human KDM4 histone demethylase family. J Biol Chem 2011; 286: 41616-41625.
22. [22] Cloos PA, Christensen J, Agger K, Maiolica A, Rappsilber J, Antal T, Hansen KH and Helin K. The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3. Nature 2006; 442: 307-311.
23. [23] Yu Y, Song C, Zhang Q, DiMaggio PA, Garcia BA, York A, Carey MF and Grunstein M. Histone H3 lysine 56 methylation regulates DNA replication through its interaction with PCNA. Mol Cell 2012; 46: 7-17.
24. [24] Bock I, Kudithipudi S, Tamas R, Kungulovski G, Dhayalan A and Jeltsch A. Application of Cel-luspots peptide arrays for the analysis of the binding specifcity of epigenetic reading domains to modifed histone tails. BMC Biochem 2011; 12: 48.
25. [25] Lee J, Thompson JR, Botuyan MV and Mer G. Distinct binding modes specify the recognition of methylated histones H3K4 and H4K20 by JMJD2A-tudor. Nat Struct Mol Biol 2008; 15: 109-111.
26. [26] Musselman CA. PHD fingers: epigenetic effectors and potential drug targets. Mol Interv 2009; 9: 314-323.
27. [27] Musselman CA. Handpicking epigenetic marks with PHD fngers. Nucleic Acids Res 2011; 39: 9061-9071.
28. [28] Yang ZQ, Imoto I, Fukuda Y, Pimkhaokham A, Shimada Y, Imamura M, Sugano S, Nakamura Y and Inazawa J. Identification of a novel gene, GASC1, within an amplicon at 9p23-24 frequently detected in esophageal cancer cell lines. Cancer Res 2000; 60: 4735-4739.
29. [29] Zhang QJ, Chen HZ, Wang L, Liu DP, Hill JA and Liu ZP. The histone trimethyllysine demethyl-ase JMJD2A promotes cardiac hypertrophy in response to hypertrophic stimuli in mice. J Clin Invest 2011; 121: 2447-2456.
30. [30] Iwamori N, Zhao M, Meistrich ML and Matzuk MM. The testis-enriched histone demethylase, KDM4D, regulates methylation of histone H3 lysine 9 during spermatogenesis in the mouse but is dispensable for fertility. Biol Reprod 2011; 84: 1225-1234.
31. [31] Krupp M. RNA-Seq Atlas--a reference database for gene expression profling in normal tissue by next-generation sequencing. Bioinformatics 2012; 28: 1184-1185.
32. [32] Shin S and Janknecht R. Diversity within the JMJD2 histone demethylase family. Biochem Biophys Res Commun 2007; 353: 973-977.
33. [33] Tsurumi A. Drosophila Kdm4 demethylases in histone H3 lysine 9 demethylation and ecdys-teroid signaling. Sci Rep 2013; 3: 2894.
34. [34] Black JC, Allen A, Van Rechem C, Forbes E, Longworth M, Tschöp K, Rinehart C, Quiton J, Walsh R, Smallwood A, Dyson NJ and Whets-tine JR. Conserved antagonism between JMJ-D2A/KDM4A and HP1γ during cell cycle progression. Mol Cell 2010; 40: 736-748.
35. [35] Skarnes WC. A conditional knockout resource for the genome-wide study of mouse gene function. Nature 2011; 474: 337-342.
36. [36] Kawazu M, Saso K, Tong KI, McQuire T, Goto K, Son DO, Wakeham A, Miyagishi M, Mak TW and Okada H. Histone demethylase JMJD2B functions as a co-factor of estrogen receptor in breast cancer proliferation and mammary gland development. PLoS One 2011; 6: e17830.
37. [37] Eppig JT. The Mouse Genome Database (MGD): comprehensive resource for genetics and ge-nomics of the laboratory mouse. Nucleic Acids Res 2012; 40: D881-886.
38. [38] Wan M, Liang J, Xiong Y, Shi F, Zhang Y, Lu W, He Q, Yang D, Chen R, Liu D, Barton M and Songyang Z. The trithorax group protein Ash2l is essential for pluripotency and maintaining open chromatin in embryonic stem cells. J Biol Chem 2013; 288: 5039-5048.
39. [39] Wang J, Zhang M, Zhang Y, Kou Z, Han Z, Chen DY, Sun QY and Gao S. The histone demethyl-ase JMJD2C is stage-specifcally expressed in preimplantation mouse embryos and is required for embryonic development. Biol Re-prod 2010; 82: 105-111.
40. [40] Zhang D, Yoon HG and Wong J. JMJD2A is a novel N-CoR-interacting protein and is involved in repression of the human transcription factor achaete scute-like homologue 2 (ASCL2/ Hash2). Mol Cell Biol 2005; 25: 6404-6414.
41. [41] Strobl-Mazzulla PH, Sauka-Spengler T and Bronner-Fraser M. Histone demethylase Jmj-D2A regulates neural crest specifcation. Dev Cell 2010; 19: 460-468.
42. [42] Verrier L, Escafft F, Chailleux C, Trouche D and Vandromme M. A new isoform of the histone demethylase JMJD2A/KDM4A is required for skeletal muscle differentiation. PLoS Genet 2011; 7: e1001390.
43. [43] Ye L, Fan Z, Yu B, Chang J, Al Hezaimi K, Zhou X, Park NH and Wang CY. Histone demethylas-es KDM4B and KDM6B promotes osteogenic differentiation of human MSCs. Cell Stem Cell 2012; 11: 50-61.
44. [44] Lu C, Ward PS, Kapoor GS, Rohle D, Turcan S, Abdel-Wahab O, Edwards CR, Khanin R, Figueroa ME, Melnick A, Wellen KE, O’Rourke DM, Berger SL, Chan TA, Levine RL, Melling-hoff IK and Thompson CB. IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature 2012; 483: 474-478.
45. [45] Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K and Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-872.
46. [46] Ma DK, Chiang CH, Ponnusamy K, Ming GL and Song H. G9a and Jhdm2a regulate embryonic stem cell fusion-induced reprogramming of adult neural stem cells. Stem Cells 2008; 26: 2131-2141.
47. [47] Loh YH, Zhang W, Chen X, George J and Ng HH. Jmjd1a and Jmjd2c histone H3 Lys 9 demeth-ylases regulate self-renewal in embryonic stem cells. Genes Dev 2007; 21: 2545-2557.
48. [48] Wagner RT and Cooney AJ. OCT4: less is more. Cell Res 2009; 19: 527-528.
49. [49] Tan MK, Lim HJ and Harper JW. SCF(FBXO22) regulates histone H3 lysine 9 and 36 methyla-tion levels by targeting histone demethylase KDM4A for ubiquitin-mediated proteasomal degradation. Mol Cell Biol 2011; 31: 3687-3699.
50. [50] Van Rechem C. The SKP1-Cul1-F-box and leu-cine-rich repeat protein 4 (SCF-FbxL4) ubiqui-tin ligase regulates lysine demethylase 4A (KDM4A)/Jumonji domain-containing 2A (JMJ-D2A) protein. J Biol Chem 2011; 286: 30462-30470.
51. [51] Mallette FA, Mattiroli F, Cui G, Young LC, Hend-zel MJ, Mer G, Sixma TK and Richard S. RNF8-and RNF168-dependent degradation of KD-M4A/JMJD2A triggers 53BP1 recruitment to DNA damage sites. EMBO J 2012; 31: 1865-1878.
52. [52] Ipenberg I, Guttmann-Raviv N, Khoury HP, Ku-pershmit I and Ayoub N. Heat shock protein 90 (Hsp90) selectively regulates the stability of KDM4B/JMJD2B histone demethylase. J Biol Chem 2013; 288: 14681-14687.
53. [53] Le May N, Iltis I, Amé JC, Zhovmer A, Biard D, Egly JM, Schreiber V and Coin F. Poly (ADP-Ri-bose) Glycohydrolase Regulates Retinoic Acid Receptor-Mediated Gene Expression. Mol Cell 2012; 48: 785-798.
54. [54] Burton A, Azevedo C, Andreassi C, Riccio A, Sa-iardi A. Inositol pyrophosphates regulate JM-JD2C-dependent histone demethylation. Proc Natl Acad Sci U S A 2013 Nov 19; 110: 18970-18975.
55. [55] Tausendschön M, Dehne N, Brüne B. Hypoxia causes epigenetic gene regulation in macro-phages by attenuating Jumonji histone de-methylase activity. Cytokine 2011; 53: 256-262.
56. [56] Luo W, Chang R, Zhong J, Pandey A, Semenza GL. Histone demethylase JMJD2C is a coacti-vator for hypoxia-inducible factor 1 that is required for breast cancer progression. Proc Natl Acad Sci U S A 2012; 109: E3367-3376.
57. [57] Coffey K, Rogerson L, Ryan-Munden C, Alkhara-if D, Stockley J, Heer R, Sahadevan K, O’Neill D, Jones D, Darby S, Staller P, Mantilla A, Gaughan L, Robson CN. The lysine demethyl-ase, KDM4B, is a key molecule in androgen receptor signalling and turnover. Nucleic Acids Res 2013; 41: 4433-4446.
58. [58] Ponnaluri VK, Vavilala DT, Putty S, Gutheil WG and Mukherji M. Identifcation of non-histone substrates for JMJD2A-C histone demethylas-es. Biochem Biophys Res Commun 2009; 390: 280-284.
59. [59] Yang L, Lin C, Liu W, Zhang J, Ohgi Kenneth A, Grinstein Jonathan D, Dorrestein Pieter C and Rosenfeld Michael G. ncRNA- and Pc2 Methyl-ation-Dependent Gene Relocation between Nuclear Structures Mediates Gene Activation Programs. Cell 2011; 147: 773-788.
60. [60] Gray SG, Iglesias AH, Lizcano F, Villanueva R, Camelo S, Jingu H, Teh BT, Koibuchi N, Chin WW, Kokkotou E and Dangond F. Functional characterization of JMJD2A, a histone deacety-lase- and retinoblastoma-binding protein. J Biol Chem 2005; 280: 28507-28518.
61. [61] Young LC, McDonald DW and Hendzel MJ. Kd-m4b Histone Demethylase Is a DNA Damage Response Protein and Confers a Survival Ad-vantage following γ-Irradiation. J Biol Chem 2013; 288: 21376-21388.
62. [62] Black JC, Manning AL, Van Rechem C, Kim J, Ladd B, Cho J, Pineda CM, Murphy N, Daniels DL, Montagna C, Lewis PW, Glass K, Allis CD, Dyson NJ, Getz G and Whetstine JR. KDM4A lysine demethylase induces site-specifc copy gain and rereplication of regions amplifed in tumors. Cell 2013; 154: 541-555.
63. [63] Young LC and Hendzel MJ. The oncogenic potential of Jumonji D2 (JMJD2/KDM4) histone demethylase overexpression. Biochem Cell Biol 2013; 91: 369-377.
64. [64] Italiano A, Attias R, Aurias A, Pérot G, Burel-Vandenbos F, Otto J, Venissac N and Pedeu-tour F. Molecular cytogenetic characterization of a metastatic lung sarcomatoid carcinoma: 9p23 neocentromere and 9p23-p24 amplifca-tion including JAK2 and JMJD2C. Cancer Genet Cytogenet 2006; 167: 122-130.
65. [65] Liu G, Bollig-Fischer A, Kreike B, van de Vijver MJ, Abrams J, Ethier SP and Yang ZQ. Genomic amplifcation and oncogenic properties of the GASC1 histone demethylase gene in breast cancer. Oncogene 2009; 28: 4491-4500.
66. [66] Vinatzer U, Gollinger M, Müllauer L, Raderer M, Chott A and Streubel B. Mucosa-associated lymphoid tissue lymphoma: novel transloca-tions including rearrangements of ODZ2, JM-JD2C, and CNN3. Clin Cancer Res 2008; 14: 6426-6431.
67. [67] Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C and Schultz N. The cBio cancer ge-nomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012; 2: 401-404.
68. [68] Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, Cerami E, Sander C and Schultz N. Integrative Analysis of Complex Cancer Ge-nomics and Clinical Profles Using the cBioPor-tal. Sci Signal 2013 Apr 2; 6: pl 1.
69. [69] Zack TI. Pan-cancer patterns of somatic copy number alteration. Nat Genet 2013; 45: 1134-1140.
70. [70] Mallette FA and Richard S. JMJD2A promotes cellular transformation by blocking cellular senescence through transcriptional repression of the tumor suppressor CHD5. Cell Rep 2012; 2: 1233-1243.
71. [71] Yang J. The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hy-poxia, and is a key mediator of estrogen induced growth. Cancer Res 2010; 70: 6456-6466.
72. [72] Shi L, Sun L, Li Q, Liang J, Yu W, Yi X, Yang X, Li Y, Han X, Zhang Y, Xuan C, Yao Z, Shang Y. His-tone demethylase JMJD2B coordinates H3K4/ H3K9 methylation and promotes hormonally responsive breast carcinogenesis. Proc Natl Acad Sci U S A 2011; 108: 7541-7546.
73. [73] Li W, Zhao L, Zang W, Liu Z, Chen L, Liu T, Xu D and Jia J. Histone demethylase JMJD2B is required for tumor cell proliferation and survival and is overexpressed in gastric cancer. Bio-chem Biophys Res Commun 2011; 416: 372-378.
74. [74] Liu Y. An epigenetic role for PRL-3 as a regulator of H3K9 methylation in colorectal cancer. Gut 2013; 62: 571-581.
75. [75] Beyer S, Kristensen MM, Jensen KS, Johansen JV and Staller P. The histone demethylases JM-JD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF. J Biol Chem 2008; 283: 36542-36552.
76. [76] Ehrbrecht A, Muller U, Wolter M, Hoischen A, Koch A, Radlwimmer B, Actor B, Mincheva A, Pietsch T, Lichter P, Reifenberger G and Weber RG. Comprehensive genomic analysis of des-moplastic medulloblastomas: identifcation of novel amplifed genes and separate evaluation of the different histological components. J Pathol 2006; 208: 554-563.
77. [77] Hélias C, Struski S, Gervais C, Leymarie V, Mauvieux L, Herbrecht R and Lessard M. Poly-cythemia vera transforming to acute myeloid leukemia and complex abnormalities including 9p homogeneously staining region with ampli-fcation of MLLT3, JMJD2C, JAK2, and SMAR-CA2. Cancer Genet Cytogenet 2008; 180: 51-55.
78. [78] Northcott PA, Nakahara Y, Wu X, Feuk L, Ellison DW, Croul S, Mack S, Kongkham PN, Peacock J, Dubuc A, Ra YS, Zilberberg K, McLeod J, Scherer SW, Sunil Rao J, Eberhart CG, Gra-jkowska W, Gillespie Y, Lach B, Grundy R, Pollack IF, Hamilton RL, Van Meter T, Carlotti CG, Boop F, Bigner D, Gilbertson RJ, Rutka JT and Taylor MD. Multiple recurrent genetic events converge on control of histone lysine methyla-tion in medulloblastoma. Nat Genet 2009; 41: 465-472.
79. [79] Sun LL, Holowatyj A, Xu XE, Wu JY, Wu ZY, Shen JH, Wang SH, Li EM, Yang ZQ and Xu LY. His-tone demethylase GASC1, a potential prognostic and predictive marker in esophageal squa-mous cell carcinoma. Am J Cancer Res 2013; 3: 509-517.
80. [80] Ishimura A, Terashima M, Kimura H, Akagi K, Suzuki Y, Sugano S and Suzuki T. Jmjd2c his-tone demethylase enhances the expression of Mdm2 oncogene. Biochem Biophys Res Com-mun 2009; 389: 366-371.
81. [81] Wissmann M, Yin N, Muller JM, Greschik H, Fodor BD, Jenuwein T, Vogler C, Schneider R, Gunther T, Buettner R, Metzger E and Schule R. Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression. Nat Cell Biol 2007; 9: 347-353.
82. [82] Wu J, Liu S, Liu G, Dombkowski A, Abrams J, Martin-Trevino R, Wicha MS, Ethier SP and Yang ZQ. Identifcation and functional analysis of 9p24 amplifed genes in human breast cancer. Oncogene 2012; 31: 333-341.
83. [83] Farnie G and Clarke RB. Mammary stem cells and breast cancer--role of Notch signalling. Stem Cell Rev 2007; 3: 169-175.
84. [84] Shin S and Janknecht R. Activation of andro-gen receptor by histone demethylases JMJD2A and JMJD2D. Biochem Biophys Res Commun 2007; 359: 742-746.
85. [85] Slee RB, Steiner CM, Herbert BS, Vance GH, Hickey RJ, Schwarz T, Christan S, Radovich M, Schneider BP, Schindelhauer D and Grimes BR. Cancer-associated alteration of pericentro-meric heterochromatin may contribute to chromosome instability. Oncogene 2012; 31: 3244-3253.
86. [86] Rabkin SW and Klassen SS. Jumonji is a potential regulatory factor mediating nitric oxide-induced modulation of cardiac hypertrophy. J Cardiovasc Med (Hagerstown) 2009; 10: 206-211.
87. [87] Zhao M, Liang G, Wu X, Wang S, Zhang P, Su Y, Yin H, Tan Y, Zhang J, Lu Q. Abnormal epigene-tic modifcations in peripheral blood mononu-clear cells from patients with alopecia areata. Br J Dermatol 2012; 166: 226-273.
88. [88] Liang Y. Targeting the JMJD2 histone demethyl-ases to epigenetically control herpesvirus infection and reactivation from latency. Sci Transl Med 2013; 5: 167ra5.
89. [89] Kantojarvi K, Onkamo P, Vanhala R, Alen R, Hedman M, Sajantila A, Nieminen-von Wendt T and Jarvela I. Analysis of 9p24 and 11p12-13 regions in autism spectrum disorders: rs1340513 in the JMJD2C gene is associated with ASDs in Finnish sample. Psychiatr Genet 2010; 20: 102-108.
90. [90] Wang KS, Liu X, Zhang Q, Wu LY, Zeng M. Genome-wide association study identifes 5q21 and 9p24.1 (KDM4C) loci associated with alcohol withdrawal symptoms. J Neural Transm 2012; 119: 425-433.
91. [91] Itoh Y, Suzuki T and Miyata N. Small-molecular modulators of cancer-associated epigenetic mechanisms. Mol Biosyst 2013; 9: 873-896.
92. [92] Hamada S, Kim TD, Suzuki T, Itoh Y, Tsumoto H, Nakagawa H, Janknecht R and Miyata N. Synthesis and activity of N-oxalylglycine and its derivatives as Jumonji C-domain-containing histone lysine demethylase inhibitors. Bioorg Med Chem Lett 2009; 19: 2852-2855.
93. [93] Hamada S, Suzuki T, Mino K, Koseki K, Oehme F, Flamme I, Ozasa H, Itoh Y, Ogasawara D, Ko-maarashi H, Kato A, Tsumoto H, Nakagawa H, Hasegawa M, Sasaki R, Mizukami T and Miya-ta N. Design, synthesis, enzyme-inhibitory activity, and effect on human cancer cells of a novel series of jumonji domain-containing protein 2 histone demethylase inhibitors. J Med Chem 2010; 53: 5629-5638.
94. [94] Sekirnik R, Rose NR, Thalhammer A, Seden PT, Mecinovic J and Schofeld CJ. Inhibition of the histone lysine demethylase JMJD2A by ejection of structural Zn(II). Chem Commun (Camb) 2009; 6376-6378.
95. [95] Rose NR, Ng SS, Mecinović J, Liénard BM, Bel-lo SH, Sun Z, McDonough MA, Oppermann U and Schofeld CJ. Inhibitor scaffolds for 2-oxo-glutarate-dependent histone lysine demethyl-ases. J Med Chem 2008; 51: 7053-7056.
96. [96] Rose NR, Woon EC, Kingham GL, King ON, Mecinovic J, Clifton IJ, Ng SS, Talib-Hardy J, Op-permann U, McDonough MA and Schofeld CJ. Selective inhibitors of the JMJD2 histone de-methylases: combined nondenaturing mass spectrometric screening and crystallographic approaches. J Med Chem 2010; 53: 1810-1818.
97. [97] King ON, Li XS, Sakurai M, Kawamura A, Rose NR, Ng SS, Quinn AM, Rai G, Mott BT, Beswick P, Klose RJ, Oppermann U, Jadhav A, Height-man TD, Maloney DJ, Schofeld CJ and Sime-onov A. Quantitative high-throughput screening identifes 8-hydroxyquinolines as cell-active histone demethylase inhibitors. PLoS One 2010; 5: e15535.
98. [98] Giri NC, Passantino L, Sun H, Zoroddu MA, Costa M and Maroney MJ. Structural investigations of the nickel-induced inhibition of truncated constructs of the JMJD2 family of his-tone demethylases using X-ray absorption spectroscopy. Biochemistry 2013; 52: 4168-4183.
99. [99] Wagner EK, Nath N, Flemming R, Feltenberger JB and Denu JM. Identifcation and characterization of small molecule inhibitors of a plant homeodomain fnger. Biochemistry 2012; 51: 8293-8306.
100. [100] Luo X, Liu Y, Kubicek S, Myllyharju J, Tumber A, Ng S, Che KH, Podoll J, Heightman TD, Opper-mann U, Schreiber SL and Wang X. A selective inhibitor and probe of the cellular functions of Jumonji C domain-containing histone demeth-ylases. J Am Chem Soc 2011; 133: 9451-9456.
101. [101] Wang L, Chang J, Varghese D, Dellinger M, Kumar S, Best AM, Ruiz J, Bruick R, Pena-Llopis S, Xu J, Babinski DJ, Frantz DE, Brekken RA, Quinn AM, Simeonov A, Easmon J and Martinez ED. A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth. Nat Commun 2013; 4: 2035.